CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Goodwill, Impaired, Accumulated Impairment Loss
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Goodwill, Impaired, Accumulated Impairment Loss of $1.00 billion as of 2022-12-31, per its 10-K filed 2024-02-14.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillImpairedAccumulatedImpairmentLoss · last filed 2024-02-14
- 2022-12-31: Goodwill, Impaired, Accumulated Impairment Loss $1.00B.
- 2021-12-25: Goodwill, Impaired, Accumulated Impairment Loss $1.00B.
- 2020-12-26: Goodwill, Impaired, Accumulated Impairment Loss $1.00B.
- 2019-12-28: Goodwill, Impaired, Accumulated Impairment Loss $1.00B.
| Period end | Goodwill, Impaired, Accumulated Impairment Loss | Goodwill, Impaired, Accumulated Impairment Loss as first filed |
|---|---|---|
| 2022-12-31 | $1.00B 10-K · filed 2024-02-14 | |
| 2021-12-25 | $1.00B 10-K · filed 2022-02-16 | |
| 2020-12-26 | $1.00B 10-K · filed 2022-02-16 | |
| 2019-12-28 | $1.00B 10-K · filed 2022-02-16 | |
| 2018-12-29 | $1.00B 10-K · filed 2021-02-17 | |
| 2017-12-30 | $1.00B 10-K · filed 2020-02-11 | |
| 2016-12-31 | $1.00B 10-K · filed 2019-02-13 | |
| 2015-12-26 | $1.00B 10-K · filed 2018-02-13 | |
| 2014-09-27 | -$1.00B 10-Q · filed 2014-10-30 | |
| 2014-06-28 | -$1.00B 10-Q · filed 2014-08-07 | |
| 2014-03-29 | $1.00B 10-Q · filed 2014-04-30 | |
| 2013-12-28 | -$1.00B 10-Q · filed 2014-10-30 | $1.00B 10-Q · filed 2014-04-30 |
| 2013-09-28 | $1.00B 10-Q · filed 2013-10-30 | |
| 2013-06-29 | $1.00B 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $1.00B 10-Q · filed 2013-05-08 | |
| 2012-12-29 | $1.00B 10-Q · filed 2013-10-30 | |
| 2012-09-29 | $1.00B 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $1.00B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $1.00B 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $1.00B 10-K · filed 2013-02-27 | |
| 2011-09-24 | $1.00B 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $1.00B 10-Q · filed 2011-08-03 | |
| 2010-12-25 | $1.00B 10-K · filed 2013-02-27 | |
| 2009-12-26 | $700.00M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |